 EAST SETAUKET, NY, Feb. 24, 2021 GLOBE NEWSWIRE -- Lixte Biotechnology Holdings, Inc . Nasdaq: LIXT, a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, will participate in the virtual H.C. Wainwright Global Life Sciences Conference, being held March 9-10, 2021. Investors may register and consult the conference agenda at the event website . 